Form 8-K - Current report:
SEC Accession No. 0001193125-16-764656
Filing Date
2016-11-10
Accepted
2016-11-09 19:12:32
Documents
3
Period of Report
2016-11-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d290694d8k.htm 8-K 12112
2 EX-99.1 d290694dex991.htm EX-99.1 14741
3 GRAPHIC g290694g1110033012962.jpg GRAPHIC 2960
  Complete submission text file 0001193125-16-764656.txt   32499
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-21898 | Film No.: 161985569
SIC: 2834 Pharmaceutical Preparations